Degenerative Myelopathy (DM) Rehabilitation
Overview
Degenerative myelopathy (DM) is a progressive, non-painful neurodegenerative disease that most commonly begins as a chronic T3–L3 myelopathy. Dogs typically develop pelvic limb proprioceptive ataxia and weakness, followed by progressive loss of ambulation and, in advanced disease, generalized weakness and respiratory compromise.
Rehabilitation cannot stop the underlying neurodegeneration. Its role is to preserve safe mobility, maintain meaningful activity, prevent secondary complications, and support the dog and caregiver throughout functional decline.
Key Clinical Points
Rehabilitation should begin while the dog is still ambulatory
Early intervention provides the greatest opportunity to preserve strength, coordination, and functional mobility.
Do not wait for significant weakness or loss of ambulation before initiating rehabilitation.
Activity dose matters
Evidence supports frequent, structured rehabilitation rather than low-dose or inconsistent treatment.
Prioritize repetitive, task-specific locomotor activity while avoiding function-limiting fatigue.
Treat function, not the calendar
DM progression is variable, and rehabilitation should follow functional level rather than time since diagnosis.
Reassess objective function at least every 4 weeks and modify treatment as mobility changes.
“With degenerative myelopathy, rehabilitation cannot stop the disease—but it can help preserve safe mobility, meaningful activity, and quality of life throughout functional decline.”
Rehabilitation Priorities
Preserve safe ambulation for as long as possible.
Maintain strength, coordination, postural control, and endurance.
Use repetitive, task-specific locomotor training as the foundation of treatment.
Evidence Snapshot
Intensive, structured physiotherapy has been associated with longer maintenance of ambulation and survival compared with lower-intensity or absent rehabilitation in dogs with DM.
Rehabilitation benefit appears to be related to frequency and amount of purposeful activity, rather than any single modality.
Underwater treadmill training can increase opportunities for repetitive, coordinated stepping while reducing effective body weight and fall risk.
Clinical Pearls
Gait quality over quantity: Stop or modify exercise when coordination deteriorates or function-limiting fatigue develops.
Introduce assistive devices early; they are tools for preserving participation, not simply end-stage equipment.
Quality of life is not defined by independent walking alone.
Continue Learning
View the complete rehabilitation protocol.
Deliver home exercise programs and client education.
-
Bouché, A. F., Levine, J. M., & Vitale, C. (2023). Diagnosis and management of dogs with degenerative myelopathy: A survey of neurologists and rehabilitation professionals. Journal of Veterinary Internal Medicine, 37(2), 1322–1329. https://doi.org/10.1111/jvim.16663
Gouveia, M. A. F., Moniz, M. A. M. S., de Oliveira, A. L., de Carvalho, D. C. E., de Moura Chaves, J. S., Korimá, Á. B., ... Bavaresco, L. (2023). Intensive neurorehabilitation and allogeneic stem cells transplantation in canine degenerative myelopathy. Frontiers in Veterinary Science, 10, Article 10374290. https://doi.org/10.3389/fvets.2023.10374290
Kathmann, I., Cizinauskas, S., Doherr, M. G., Steffen, F., & Jaggy, A. (2006). Daily controlled physiotherapy increases survival time in dogs with suspected degenerative myelopathy. Journal of Veterinary Internal Medicine, 20(4), 927–932. https://doi.org/10.1892/0891-6640(2006)20[927:DCPIS]2.0.CO;2
Kobatake, Y., Nakata, K., Sakai, H., Sasaki, J., Yamato, O., Takashima, S., Nishii, N., Maeda, S., Islam,M. S., & Kamishina, H. (2021). The long-term clinical course of canine degenerative myelopathy and therapeutic potential of curcumin. Veterinary Sciences, 8(9), 192. https://doi.org/10.3390/vetsci8090192
Kowal, J. B., Verga, S. A., Pandeya, S. R., Cochran, R. J., Rutkove, S. B., & Coates, J. R. (2022). Electrical impedance myography in dogs with degenerative myelopathy. Frontiers in Veterinary Science, 9, Article 874277. https://doi.org/10.3389/fvets.2022.874277
Degenerative Myelopathy (DM) Rehabilitation FAQ
-
Rehabilitation should begin as early as possible while the dog remains independently ambulatory. Early treatment focuses on preserving strength, coordination, postural control, endurance, and safe mobility rather than waiting for significant functional decline.
-
No. Rehabilitation has not been shown to stop the underlying neurodegenerative disease. Structured, frequent rehabilitation can help preserve function, maintain meaningful activity, manage secondary complications, and support quality of life as the disease progresses.
-
Exercise should be frequent, structured, and individualized. Multiple short bouts of purposeful activity are generally preferred to prolonged exercise. Treatment should be modified when gait quality deteriorates and should not create function-limiting fatigue.
-
Assistive devices should be introduced before mobility becomes unsafe. Rear-support harnesses, slings, carts, and environmental modifications can reduce falls, preserve participation, and allow dogs to remain safely active as neurologic function declines.
-
The primary goal is to preserve meaningful function and quality of life for as long as possible. As the disease progresses, rehabilitation goals shift from maintaining independent ambulation to supported mobility, prevention of secondary complications, comfort, caregiver support, and continued participation in activities the dog enjoys.
To learn more, download the Degenerative Myelopathy Treatment Protocol Workbook today for complete rehabilitation guidelines and clinical decision-making resources.
